Debt-to-Equity Ratio

The Debt-to-Equity (D/E) ratio measures how much a company uses debt versus shareholder equity to finance its assets; a ratio of 0.83x means Thermo Fisher carries $0.83 of debt for every $1 of equity.

This is higher than the healthcare sector median of 0.45x, placing the company in the 70th percentile among peers — indicating above-average leverage relative to its industry. Trend data is not available: year-over-year change, quarter-over-quarter change, and the last eight quarters are all marked N/A, so no directional insight can be drawn. Without trend information, the combination of an elevated D/E ratio (above the sector median) and a lack of movement data adds uncertainty: it suggests higher financial risk from debt but offers no indication of whether that risk is increasing or decreasing. This metric neither supports nor contradicts the overall NEUTRAL verdict — the absence of trend makes it a static point, and the level alone is not extreme enough to alter the balanced view.

Frequently Asked Questions

Closest Sector Peers